Christopher Mason's Insider Trades & SAST Disclosures
Christopher Mason's most recent trade in Krystal Biotech Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher Mason.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | Christopher Mason | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Christopher Mason | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 6,800 | 6,800 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Christopher Mason | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 6,800 | 6,800 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Christopher Mason | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 6,800 | 6,800 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Christopher Mason | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Christopher Mason | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 13,600 | 13,600 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges